
Aurora Cannabis Inc.
ACBNASDAQHealthcareDrug Manufacturers - Specialty & Generic
Previous close
$3.94
+$0.13 · +3.41%
ACB company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
47
Fair Value
Momentum
21
Weakening
Sentiment
46
Mixed
Risk resilience
38
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteAurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Headquarters
- CA
- CEO
- Miguel Martin
- Listed since
- Jul 15, 2014
- Employees
- 1,028
Market position
Day range
Current $3.94
52-week range
Current $3.94
- Open
- $3.825
- Previous close
- $3.81
- Volume
- 1.37M
- 1.01× average
- Average volume
- 1.36M
- Average daily volume
- Market cap
- 244.05M USD
- Beta
- 1.34
- Market reference 1
- 50-day average
- $2.9653
- +32.87% above average
- 200-day average
- $3.6601
- +7.65% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 169.2M CAD
- P/E (TTM)
- -2.81×
- P/B (TTM)
- 0.64×
- P/S (TTM)
- 1.16×
- EV / EBITDA
- -3.32×
- Earnings yield
- -47.18%
- Free cash flow yield
- -13.97%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 32.08%
- Operating margin
- -29.66%
- Net margin
- -38.15%
- Return on equity
- -23.73%
- Return on assets
- -20.20%
- Return on invested capital
- -8.62%
Financial health
- Debt / equity
- 0.04×
- Current ratio
- 5.94×
- Altman Z-score
- -11.67
- Piotroski F-score
- 2 of 9
Earnings
- EPS beat rate
- 36%
- 4 beats, 7 misses, 0 met estimates
- Average EPS surprise
- +713.92%
- 11 comparable reports
- Latest EPS result
- -0.05
- Estimate -0.13 · Beat by 64.60%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
14 ratingsCorporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Feb 20, 2024 | 1:10 | — | — |
Stock split | May 11, 2020 | 1:12 | — | — |
Effective Feb 20, 2024
1:10
Effective May 11, 2020
1:12
ACB peers
ETFs holding ACB
Funds reporting this stock among their holdings, ordered by reported position size.
Amplify Alternative Harvest ETFMJ- Market value
- 5.08M
- Weight
- 4.28%
- AUM
- 118.56M USD
- Expense ratio
- 1.12%
- Price / 1D
- $26.35+1.62%
AdvisorShares Pure Cannabis ETFYOLO- Market value
- 1.3M
- Weight
- 3.58%
- AUM
- 36.39M USD
- Expense ratio
- 0.91%
- Price / 1D
- $3.06+3.03%
Dimensional - International Core Equity 2 ETFDFIC- Market value
- 27.15K
- Weight
- 0.00%
- AUM
- 15.43B USD
- Expense ratio
- 0.22%
- Price / 1D
- $39.405+0.83%
Continue in GoAI
Research ACBresearch.disclaimer





